Outcomes After Spinal Cord Injury (OASIS)
Prolonged Exposure Therapy (PE) for Posttraumatic Stress Disorder (PTSD) in Spinal Cord Injury (SCI): a Randomized Controlled Trial
1 other identifier
interventional
30
1 country
1
Brief Summary
The study evaluates the effectiveness of Prolonged Exposure Therapy on a population of individuals with spinal cord injuries. Participants will be randomly assigned to either a treatment as usual or Prolonged Exposure therapy group.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 21, 2018
CompletedFirst Submitted
Initial submission to the registry
July 25, 2018
CompletedFirst Posted
Study publicly available on registry
August 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 6, 2026
CompletedJanuary 23, 2026
January 1, 2026
3.1 years
July 25, 2018
January 22, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The PTSD Symptom Scale - Interview for DSM-5 (PSSI-5)
The PSSI-5 is a 24-item, semi-structured interview that assesses PTSD symptoms in the past two weeks, and makes a diagnostic determination based on the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5) criteria. The interviewer rates participant responses to symptom questions on a 5-point scale of frequency and severity, from 0 ("Not at all") to 4 ("6 or more times a week/severe") with a higher total score meaning more Posttraumatic stress symptoms.
Used to assess change in Posttraumatic Stress entomology at Baseline, 6 week, 10 week, and 32 week about their past two week experiences.
Secondary Outcomes (10)
The MINI International Neuropsychiatric Interview (MINI)
Assessed at Baseline about past month and lifetime experiences.
The Beck Depression Inventory-II (BDI-II)
Assessed at Baseline, at every Prolonged Therapy Session, 6 week, 10 week, and 32 week about their past month experiences.
Post-Traumatic Cognitions Inventory (PTCI)
Assessed at Baseline, at every Prolonged Therapy Session, 6 week, 10 week, and 32 week about their past month experiences.
Numerical Rating Scale (NRS)
Assessed at Baseline,10 week, and 32 week about their past week experience.
Pittsburgh Sleep Quality Index Addendum for PTSD (PSQI-A)
Assessed at Baseline,10 week, and 32 week about their past month experience.
- +5 more secondary outcomes
Study Arms (2)
Treatment as Usual
NO INTERVENTIONParticipants in the control arm will not receive the PE therapy, but they will rather receive the standard clinical treatment receive by all SCI patients at BIR. This includes an evaluation by a licensed psychologist and continued follow-up psychotherapy as needed. This therapy does not consist of trauma-focused therapy and will be summarized in the analysis as a part of standard of care. TAU participants will have a posttreatment assessment, as well as follow-up assessments at one and 6 months
Intervention
EXPERIMENTALParticipants randomized to the PE intervention will receive 2-3, 60-minute sessions each week for 4-6 weeks (12 total sessions). Treatment is manualized, and includes education about common reactions to trauma, breathing retraining, prolonged (repeated) imaginal exposure to trauma memories, repeated in vivo exposure to situations that participants are avoiding due to trauma-related fear, and discussion of thoughts and feelings related to exposure exercises.
Interventions
Using a combination of In vivo and Imaginal exposure, Prolonged Exposure therapy aims to treat those with Posttraumatic Stress Disorder.
Eligibility Criteria
You may qualify if:
- Patients admitted to the trauma service at BUMC or Inpatient service at BIR
- Patients with SCI
- Patients at least 30 days post injury (to insure proper PTSD diagnosis)
- Patients ages 18 and older
- Patients who have a positive PTSD screen using PTSD Symptom Scale - Interview for DSM-5 (PSSI-5)
You may not qualify if:
- Patients in police custody
- Non-English speaking
- Patients with severe cognitive impairment (will be assessed through chart review and with the Cognistat)
- Patients who are acutely suicidal and/or have been admitted for a suicide attempt
- Patients who are actively psychotic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baylor Scott & White Institute for Rehabilitation
Dallas, Texas, 75246, United States
Related Publications (1)
Douglas ME, Bennett M, Jones KA, Pogue JR, Chauvette GV, Sikka S, Driver S, Hamilton R, Curcio N, Patel S, Wierzchowski A, Adams M, Thomas EV, Turner E, Leonard K, Carl E, Foreman M, Warren AM, Powers MB. Prolonged exposure for posttraumatic stress disorder following spinal cord injury: A randomized controlled trial. Rehabil Psychol. 2025 Aug;70(3):240-254. doi: 10.1037/rep0000580. Epub 2024 Aug 29.
PMID: 39207423DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2018
First Posted
August 10, 2018
Study Start
February 21, 2018
Primary Completion
March 30, 2021
Study Completion
January 6, 2026
Last Updated
January 23, 2026
Record last verified: 2026-01